QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced the regulatory approval of its therascreen ® EGFR Mutation Detection Kit RGQ in Japan. EGFR, the epidermal growth factor receptor, ...
Company will work with ImClone and BMS to develop FDA-approved test for mCRC patients. DxS is to work with ImClone Systems and Bristol-Myers Squibb on the development of a companion diagnostic for the ...
Mutation Detection Kits in Genome Editing Market · GlobeNewswire Inc. Dublin, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The "Mutation Detection Kits in Genome Editing Market Report 2025" has been added to ...
The US Food and Drug Administration (FDA) has granted approval for EntroGen's CRCdx RAS Mutation Detection Kit as a companion diagnostic for Vectibix (panitumumab), a targeted therapy used in the ...
Assures 100x upgraded detection sensitivity compare to ddPCR Higher the possibility of precision medicine in the 1st and 2nd stages of cancer patients SEOUL, South Korea--(BUSINESS WIRE)--GENECAST, ...
Testing for genetic mutations has long been complicated, expensive, time-consuming, and, in some parts of the world, inaccessible. Dr. Pierre Billon, an assistant professor at the University of ...
2don MSN
Base editing repairs mutation and liver function in mouse model of Zellweger spectrum disorder
In 2025, baby KJ Muldoon became the first person to receive a personalized gene editing treatment, which likely saved his ...
Transgenomic, Inc. announced that it is launching its next generation SURVEYOR Mutation Detection Kits for universal primer fluorescent capillary electrophoresis. The kits are designed to detect ...
Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments and diagnostics easier and quicker, new research has found. Working with ...
The splicing of nuclear pre-mRNA is a fundamental process for the expression of most metazoan genes. More than half of reported exonic mutations in human disease and cancers are due to ...
The Health Ministry’s discovery of a malfunction in test kits used to detect a genetic mutation especially common among Ashkenazi Jews has reportedly led to the formation of a special review committee ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results